MyFinsight
Home
Blog
About
Contact
Download
Download image
Inventory, net
$23,574K
Cash and cash
equivalents
$17,973K
Accounts receivable, net
$8,858K
Prepaid expenses and
other current assets
$2,955K
Restricted cash, current
$50K
2031 and thereafter
$19,505K
2027
$4,174K
2026
$4,174K
2028
$3,965K
2029
$3,830K
2030
$3,822K
Total current assets
$53,410K
Intangible assets, net
$39,470K
Goodwill
$24,681K
Property and equipment,
net
$9,586K
Operating lease
right-of-use assets, net
$3,250K
Total assets
$130,397K
Total liabilities and
stockholders' equity...
$130,397K
Total liabilities
$91,516K
Total stockholders'
equity (deficit)
$38,881K
Accumulated deficit
-$64,794K
Convertible debt
$31,441K
Other long-term
liabilities
$30,050K
Total current
liabilities
$25,993K
Operating lease
liabilities, net of current...
$2,752K
Deferred revenue, net of
current portion
$1,280K
Additional paid in capital
$103,675K
Accrued expenses
$15,364K
Other liabilities
$3,842K
Accounts payable
$2,986K
Contingent consideration
$2,200K
Deferred revenue,
current portion
$966K
Operating lease
liabilities, current portion
$635K
Back
Back
Balance Sheet
source: myfinsight.com
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)